WHO ICTRP trial
Hepatoprotective effect of hydrogen rich water in chronic hepatitis B patients
ChiCTR-TRC-12002760 · Chinese Clinical Trial Registry (ChiCTR) · Not Recruiting
Key facts
| Trial ID | ChiCTR-TRC-12002760 |
|---|---|
| Public title | Hepatoprotective effect of hydrogen rich water in chronic hepatitis B patients |
| Scientific title | Effect of hydrogen rich water on oxidative stress, liver function and viral load in patients with chronic hepatitis B |
| Primary sponsor | Forth People's Hospital of Huai'an City in Jiangsu Province |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Not Recruiting |
| Study type | Interventional study |
| Phase | Other |
| Countries | China |
| Conditions | Hepatitis B |
| Interventions | Routine treatment group:Routine treatment;Hydrogen treatment group:Hydrogen treatment plus routine treatment;Healthy control group:no |
| Registration date | Nov 26, 2012 |
| Target size | Routine treatment group:30;Hydrogen treatment group:30;Healthy control group:30 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: